Treatment of Sports Injuries with Glucopuncture

Glucopuncture is an injection-based therapy for the management of a variety of musculoskeletal conditions. It consists of multiple local injections with glucose or dextrose in low concentrations. The goal is to support tissue repair and to modulate referred pain. These injections of G5W (Glucose 5% in Water) or D5W (Dextrose 5% in Water) seem to have a favorable effect on the physiological repair mechanisms of damaged or inflamed tissues such as muscles, tendons, ligaments, cartilage and peripheral nerves. Patients seem to recover much quicker, and their pain subsides sooner as well, especially with repeated G5W sessions.

The exact mechanism of action of Glucopuncture is not well understood and is likely multifactorial. Large randomized controlled trials are required to make specific recommendations regarding ideal protocols and indications. The introduction of a new term to describe these injections might give more exposure to its possible benefits among patients and professional health care providers. The advantages of this method are its availability, cost benefits ratio, safety and easy application.

Glucose and dextrose injections have been used for decades in prolotherapy [1-7]. Prolotherapy - also known as proliferation therapy [8] - is an American injection technique which uses high concentrations of dextrose (more than 10% net concentration). Local anesthetics are added to make the injections less painful (usually lidocaine 0.2% or procaine 0,5% net concentration). One of the aims of such hypertonic injections is to create a local inflammatory reaction and / or to stimulate formation of scar tissue in ligaments [9]. It is postulated that these hypertonic dextrose injections stimulate tissue repair through growth factors [10] and modulate pain modulation through agonism of TRPV1 receptor [11]. In traditional prolotherapy, injections are given mainly into joint cavities, entheses and ligaments.

Over the last decade, low concentrations of glucose (or dextrose) 5% have become more popular [12-15]. Originally, these G5W injections were given subcutaneously along the Achilles tendon, because that approach was found to be less painful than the conventional prolotherapy approach which uses injections on the heel bone [16]. Using only 5% also makes it possible to give the injections without adding local anesthetics. These glucose 5% injections are administered epidermally, into muscles, in the epidural liquid, around tendons and in joints. As the clinical effect is usually temporary in the beginning, the sessions need to be repeated on a regular basis to achieve lasting clinical effect. To make the injections more effective, it is advisable to give multiple injections in the treatment zone instead of one single injection, except when giving a joint injection, an epidural injection, or a specific intralesional injection (e.g., under ultrasound guidance).

As stated before, it is also important to repeat the sessions on a regular basis. Most doctors are using series of five to ten weekly injections of glucose 5% in the treatment of osteoarthritis, Achilles tendinopathy, carpal tunnel syndrome, neck pain, low back pain, whiplash, rotator cuff, tennis elbow, failed back surgery syndrome, Osgood-Schlatter, tension headache, regional neuropathic pain and sports injuries.

Glucose is a monosaccharide which functions as a precursor for many carbohydrates. It is considered as the major energy source for cellular health. One glucose molecule results in more than 30 ATP molecules during the aerobic respiration. The conversion of ATP into ADP releases 30.6 kJ/mol energy to the cells. In other words, glucose can be considered as a direct provider of energy to cell metabolism.

When tissues are damaged because of trauma, overuse or other causes, the cells need to regenerate as quickly as possible. This physiological tissue regeneration requires an additional amount of energy. In normal circumstances, energy supply is abundant to meet the higher demand. This is especially true for young and healthy patients. But when energy supply is limited (for example, low blood circulation) or when the demands for ATP are extra high (when the tissues are damaged or inflamed), physiological recovery of the tissue may be slow, get stuck or even become impossible, leading to poor tissue healing. In this sense, Glucopuncture delivers not only faster tissue repair and pain modulation, but probably also better tissue repair. The latter is especially interesting for professional athletes.

It is postulated that injecting glucose in the extracellular space of the damaged tissue may enhance local ATP supply to the cells and as a result support and speed up local physiological tissue repair. However, there is no strong evidence for this hypothesis so far. Only one study seems to support (partially) this ATP-based concept. In this recent study the authors have illustrated that ATP injection increased expression of several markers for regenerative activity in sensory neurons, including phospho-STAT3 and GAP43 [18].

The most common sports related disorders in general practice involve ligament lesions, muscle overuse, muscle tears, bursitis and tendinopathy. A lot of athletes come to see doctors trained in Glucopuncture because they are afraid of the side effects of conventional medication and also because they want to speed up their recovery. Glucose is also not on the WADA list [18].

When addressing a patient with a sports injury, a conventional diagnosis is performed first before making a functional diagnosis. A social history should include the patient’s occupation and sport activities. One should check if previous treatments have been tried, including the use of ice, heat, or medications (e.g., acetaminophen, aspirin, nonsteroidal anti-inflammatory drugs), physical therapy, cortisone injections, hyaluronic acid injections, PRP injections, shockwave therapy or surgery. It is important to check to what extent these have been helpful or harmful.

We have two main approaches. The superficial injections are for pain modulation (A), the deeper injections are for tissue repair (B). Intradermal G5W injections are given in the zone of pain referral (A). The effect on pain modulation is sometimes immediate, but usually lasts less than an hour. For that reason, injections are repeated every week until the pain remains absent permanently.

Deeper injections are given to support tissue repair (B). When during clinical examination, pain points or trigger points are found in muscles, ligaments or tendons, these points are injected as well with G5W. Injections are also given into joint cavities. A textbook with illustrations and treatment protocols will be published soon.

None.

No conflicts of interest.

1. Reeves KD, Sit RW, Rabago DP (2016) Dextrose Prolotherapy: A Narrative Review of Basic Science, Clinical Research, and Best Treatment Recommendations. Phys Med Rehabil Clin N Am 27(4): 783-823.
2. Distel LM, Best TM (2011) Prolotherapy: a clinical review of its role in treating chronic musculoskeletal pain. PM R 3(6 Suppl 1): S78-S81.
3. Ganji R (2018) Dextrose prolotherapy for improvement of rotator cuff lesions: ready for clinical use? Hong Kong Med J 24(4): 429-430.
4. Topol GA, Podesta LA, Reeves KD, Marcia Mallma Giraldo, Lanny L Johnson et al. (2016) Chondrogenic Effect of Intra-articular Hypertonic-Dextrose (Prolotherapy) in Severe Knee Osteoarthritis. PM R 8(11): 1072–1082.
5. Rabago D, Kijowski R, Woods M, Patterson JJ, Mundt M, et al. (2013) Association between disease-specific quality of life and magnetic resonance imaging outcomes in a clinical trial of prolotherapy for knee osteoarthritis. Arch Phys Med Rehabil 94(11): 2075-282.
6. Rabago D, Nourani B (2017) Prolotherapy for Osteoarthritis and Tendinopathy: a Descriptive Review. Curr Rheumatol Rep 19(6): 34.
7. Rabago D, Kansariwala I, Marshall D, Nourani B, Stiffler-Joachim M, et al. (2019) Dextrose Prolotherapy for Symptomatic Knee Osteoarthritis: Feasibility, Acceptability, and Patient-Oriented Outcomes in a Pilot-Level Quality Improvement Project. J Altern Complement Med 25(4): 406-412.
8. Hackett GS, Hemwall GA (1993) Ligament and tendon relaxation treated by prolotherapy. 5. Oak Park: Gustav A Hemwall (eds) Montgomery GA.
9. Ekwueme EC, Mohiuddin M, Yarborough JA, Brolinson PG, Docheva D, et al. (2017) Prolotherapy induces an inflammatory response in human tenocytes in vitro. Clin Orthop Relat Res 475(8): 2117–2127.
10. Hauser RA, Lackner JB, Steilen-Matias D, Harris DK (2016) A Systematic Review of Dextrose Prolotherapy for Chronic Musculoskeletal Pain. Clin Med Insights Arthritis Musculoskelet Disord. 9: 139-159.
11. Maniquis-Smigel L, Reeves KD, Rosen JH, et al. (2017) Short term analgesic effects of 5% dextrose epidural injection for chronic low back pain. A randomized controlled trial. Anesth Pain Med 7: e42550.
12. Maniquis-Smigel L, Reeves KD, Rosen JH, John Lyftogt, Cassie Graham-Coleman, et al. (2017) Short term analgesic effects of 5% dextrose epidural injection for chronic low back pain. A randomized controlled trial. Anesth Pain Med 7(1): e42550.
13. Koroglu, Ozlem, Orscelik, Aydan, Karasimav, Ozlem, Demir, Yasin, Solmaz, İlker (2019) Is 5% dextrose prolotherapy effective for radicular low back pain? Gulhane Medical Journal 61(3): 123-127.
14. Lyftogt, John (2007) Subcutaneous prolotherapy treatment of refractory knee, shoulder, and lateral elbow pain. Australasian Musculoskel Med 12: 107-109.
15. Paprottka KJ, Lehner A, Fendler WP, Harun Ilhan, Axel Rominger, et al. (2016) Reduced periprocedural analgesia after replacement of water for injection with glucose 5% solution as the infusion medium for 90Y-Resin microspheres. J Nucl Med 57(11): 1679-1684.
16. Lyftogt J (2007) Subcutaneous prolotherapy for Achilles tendinopathy: The best solution? Australasian Musculoskeletal Medicine.
17. Wu D, Lee S, Luo J, Xia H, Gushchina S, et al. (2018) Intraneural Injection of ATP Stimulates Regeneration of Primary Sensory Axons in the Spinal Cord. J Neurosci 38(6): 1351-1365.
18. Heuberger JAAC, Cohen AF (2019) Review of WADA Prohibited Substances: Limited Evidence for Performance-Enhancing Effects. Sports Med 49(4): 525-539.